News

Pricefx Achieves Record Growth and Innovation in 2024

Pricefx Achieves Record Growth and Innovation in 2024

Pricefx Reports Exceptional Growth in 2024

MUNICH & CHICAGO—Pricefx, the global leader in cloud-native pricing software, recently reported impressive progress, showcasing a remarkable 38% rise in annual subscription revenue alongside its strongest revenue quarter ever. This success highlights the company's innovative use of AI and robust strategic partnerships.

Leadership Comments on Success

“Throughout 2024, we demonstrated our leadership in the pricing industry by empowering businesses to harness the transformative potential of AI to achieve their pricing goals,” stated Ronak Sheth, Chief Executive Officer of Pricefx. “Our clients trust us for our groundbreaking advancements that yield rapid ROI and sustainable long-term value. Through our powerful partnerships and innovative AI strategies, we enable companies to gain unparalleled pricing agility and reach profitable growth.”

AI Innovations Propel Growth

The momentum of the company’s AI innovation strategy grew significantly in 2024 with the introduction of PricingAI by Pricefx. This comprehensive toolset brings pricing science to life while offering “bring-your-own-science” capabilities. Additionally, Pricefx launched two significant product updates: Clover Club v12 and Rampur v13, both designed to enhance features like Actionable Insights, Negotiation Guidance, and List Price Optimization. These tools help customers improve margins and foster data-driven decision-making at scale.

Welcoming New Leadership

In a strategic move to bolster its AI leadership, Pricefx appointed technology expert Suzanne Valentine to oversee the PricingAI initiative. With over 25 years of experience, including her previous role as Head of Business Data Science at Meta, she brings a wealth of knowledge on using data and AI to inform strategy.

Acknowledgment and Awards

Pricefx’s commitment to quality and innovation has earned it numerous prestigious industry awards. Some highlights include:

  • Winner of the Artificial Intelligence Excellence Award in the Generative AI category.
  • 2024 American Business Awards gold winner for Business or Competitive Intelligence Solution.
  • Silver winner in the 2024 Stevie Awards for Sales & Customer Service.
  • Gold winner at the 2024 International Stevie Awards for Business or Competitive Intelligence Solution.
  • Third consecutive year as winner of the Martech Breakthrough Awards for Best Price Optimization Solution.
  • Recognized by the Globee Awards for Leadership, with Ronak Sheth honored as CEO of the Year.

These accolades underline Pricefx’s continued dedication to customer success and innovation.

Focusing on Customer Satisfaction

Pricefx’s commitment to customer success is evident in its achievement of 35 successful global customer implementations across various sectors. The company proudly maintains a 97.4% customer retention rate, emphasizing its focus on delivering lasting value.

Strategic Partnerships Drive Expansion

The Advantage Pricefx ecosystem has continued to propel revenue growth through strategic collaborations with industry leaders, including Accenture, Deloitte, SAP, and PwC. Over 90% of new implementations have been delivered through advanced system integrator partners, enhancing Pricefx's integration capabilities.

Recognition from SAP

Pricefx was honored with the 2024 SAP Pinnacle Award in the SAP Store category, recognizing its success in developing and delivering innovative solutions at scale. Competing against over 24,000 SAP partners, Pricefx stood out as one of 16 firms to win an SAP Pinnacle Award.

Future Directions and Innovations

Looking ahead, Pricefx plans to expand its innovative offerings and continue enhancing its product to meet the evolving needs of businesses. The company’s growth trajectory indicates a promising future with ongoing recognition and success in the industry.

About Pricefx

Pricefx is at the forefront of SaaS and AI pricing software, delivering quick-implement, flexible, and user-friendly solutions. Built on a cloud-native architecture, it offers a robust AI pricing optimization and management platform aimed at delivering the fastest time-to-value and highest ROI in the sector. Supporting large B2B companies across various industries, Pricefx’s approach is entirely customer-focused, ensuring satisfaction and loyalty. For more information, please visit Pricefx’s website.

Frequently Asked Questions

What are the key highlights of Pricefx's 2024 performance?

Pricefx reported a 38% increase in annual subscription revenue and its best revenue quarter, emphasizing its innovative AI solutions and customer success.

Who is leading the PricingAI initiative at Pricefx?

Suzanne Valentine, a seasoned technology expert with 25 years of experience, has been appointed to lead the PricingAI initiative.

What awards has Pricefx won recently?

Pricefx has recently won multiple awards, including the Artificial Intelligence Excellence Award and the 2024 SAP Pinnacle Award for innovation.

How does Pricefx ensure customer satisfaction?

With a 97.4% customer retention rate and numerous global implementations, Pricefx is committed to delivering lasting value and high-impact results.

What strategic partnerships has Pricefx established?

Pricefx has partnered with leading firms like Accenture, Deloitte, SAP, and PwC to enhance its offerings and drive revenue growth.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 5

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading

Top 5 Most Recently Viewed Articles

ING's Successful Share Buyback and New €1.6 Billion Plan

Updated Category News Views 246

ING Finalizes Share Buyback and Unveils New Distribution Strategy Recently, ING announced that it has successfully completed its comprehensive share buyback program. This initiative, which commenced earlier, concluded with the repurchase of an impressive total of 101,193,469 ordinary shares at an average price of €19.77, resulting in a total expenditure of approximately...

Continue Reading
Aicuris' Pritelivir Shows Promise for Immunocompromised Patients

Updated Category News Views 203

Breakthrough Results for Pritelivir in Immunocompromised Patients Pritelivir has distinguished itself in the realm of treatment for refractory Herpes Simplex Virus (HSV) infections among immunocompromised patients. The recent Phase 3 trial reported a statistically significant superiority in lesion healing compared to standard-of-care treatments, demonstrating the...

Continue Reading
Market Insights: Bitcoin's Stability Amidst Altcoin Declines

Updated Category News Views 213

Market Dynamics: Bitcoin Stands Firm as Altcoins Dwindle In a recent turn of events, leading altcoins such as Ethereum and XRP experienced significant price drops, indicating a potential shift in the cryptocurrency market's dynamics. This selloff occurred after a period of robust growth within the broader market, shaking investor confidence. Understanding the Market...

Continue Reading
American Rebel Holdings Partners with Ace Distributing in PA

Updated Category News Views 164

American Rebel Holdings Strengthens Beer Distribution Network Ace Distributing, a prestigious beer wholesaler with a rich history, has joined the American Rebel Light Beer family. This partnership marks a significant step in American Rebel's strategy to enhance its distribution network across Pennsylvania. The Partnership Breakdown American Rebel Holdings, Inc. (NASDAQ:...

Continue Reading
Core Natural Resources Delivers Strong Q3 Performance Insights

Updated Category News Views 143

Core Natural Resources Achieves Impressive Q3 Results Core Natural Resources, Inc. (NYSE: CNR) has just reported an exciting fiscal performance for its third quarter, showcasing substantial growth in net cash generated from operating activities and increased shareholder returns. Strong Financial Milestones The company generated net cash provided by operating activities...

Continue Reading